{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021392659617024.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1080/17474124.2021.1823213"}},{"identifier":{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1823213"}}],"dc:title":[{"@value":"Recurrence of hepatocellular carcinoma following liver transplantation"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021392659617025","@type":"Researcher","foaf:name":[{"@value":"Neil Mehta"}],"jpcoar:affiliationName":[{"@value":"Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021392659617024","@type":"Researcher","foaf:name":[{"@value":"Daniel Hoffman"}],"jpcoar:affiliationName":[{"@value":"Department of Surgery, University of California, San Francisco, CA, USA"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17474124"},{"@type":"EISSN","@value":"17474132"}],"prism:publicationName":[{"@value":"Expert Review of Gastroenterology & Hepatology"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2020-09-23","prism:volume":"15","prism:number":"1","prism:startingPage":"91","prism:endingPage":"102"},"reviewed":"false","url":[{"@id":"https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1823213"}],"createdAt":"2020-09-16","modifiedAt":"2024-08-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360588381052136064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816806400128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical significance of mechanistic target of rapamycin expression in vessels that encapsulate tumor cluster‐positive hepatocellular carcinoma patients who have undergone living donor liver transplantation"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1080/17474124.2021.1823213"},{"@type":"CROSSREF","@value":"10.1097/ftd.0000000000001250_references_DOI_AbCSnPL6Jqprqe9NbDiIehpMuyL"},{"@type":"CROSSREF","@value":"10.1002/ags3.12735_references_DOI_AbCSnPL6Jqprqe9NbDiIehpMuyL"}]}